Healthcare group HCA International is reportedly gearing up for a yearlong appeals process that will cost more than $3 million to fight the Competition and Markets Authority’s ruling that will require the company to divest hospitals.
The CMA released its first report this week just one day after commencing operations as the UK’s new competition regulator. The CMA ordered HCA to divest at least one of its six hospitals in London, reports say, but decided against ordering market leader BMI to divest assets.
HCA said it is “furious” with the CMA’s decision to only order such divestitures on the US-based conglomerate and no one else. BMI was originally slated to require the sale of seven hospitals.
Full Content: The Independent
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Kenya’s Competition Authority Proposes Tougher Regulations on Big Tech
May 30, 2024 by
CPI
KKR Secures EU Antitrust Approval for $24 Billion Acquisition of Telecom Italia’s Fixed-Line Network
May 30, 2024 by
CPI
European Court Sides with Tech Giants in Italian Regulatory Dispute
May 30, 2024 by
CPI
US Steel and Nippon Steel Secure International Approvals for $14.9B Merger
May 30, 2024 by
CPI
EU Watchdog Mandates Boardroom Accountability for AI in Banks
May 30, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Merger Guidelines Retrospective
May 21, 2024 by
CPI
Mergers of Complements
May 21, 2024 by
CPI
Personality Traits, Private Equity, and Merger Analysis
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Lessons in the Importance of Incipiency, Modern Economics, and Monopsony
May 21, 2024 by
CPI
The 2023 Merger Guidelines: Sharpening Merger Analysis
May 21, 2024 by
CPI